| Adam Hill, MSN | |
|
520 A Lippincott Dr., Marlton, NJ 08053 | |
| (856) 596-9057 | |
| (856) 596-0837 |
| Full Name | Adam Hill |
|---|---|
| Gender | Male |
| Speciality | Nurse Practitioner |
| Experience | 9 Years |
| Location | 520 A Lippincott Dr., Marlton, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205293438 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | 26NR13729800 (New Jersey) | Secondary |
| 363L00000X | Nurse Practitioner | 26NJ00617100 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Virtua Memorial Hospital Of Burlington County | Mount holly, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Virtua Medical Group, Pa | 9830222397 | 1226 |
News Archive
Predictive Biosciences today announced that the Company will be presenting results on the development of a real-time multiplexed PCR assay for detection of FGFR3 mutations in urine and tissue at the American Society of Clinical Oncology (ASCO) 2011 Genitourinary Cancers Symposium being held February 17 - 19 in Orlando, Florida. Results will also focus on the application of the assay which is currently being used in Predictive's first commercial molecular grading product, the CertNDxTM Molecular Grading Assay.
Laboratory Corporation of America® Holdings announced today that for the period of March 12, 2010 to September 11, 2010, its Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon Notes) will, subject to the terms of the Zero Coupon Notes, accrue contingent cash interest at a rate of no less than 0.125% of the average market price of a Zero Coupon Note for the five trading days ended March 9, 2010, in addition to the continued accrual of the original issue discount.
"Worldwide, evidence-based interventions are being implemented in an effort to drive down child mortality and there are some signs that they are working," a Lancet editorial states. "However, few countries are on course to meet the targets set by Millennium Development Goal 4," the editorial notes.
A third dose of the Pfizer-BioNTech vaccine significantly increased neutralizing antibody levels against SARS-CoV-2, the virus that causes COVID-19, according to new research published in the New England Journal of Medicine.
The Network for Excellence in Neuroscience Clinical Trials, or NeuroNEXT, a research program that helps streamline Phase II clinical trials for brain disorders, has been renewed for five more years, with several new centers joining the program
› Verified 3 days ago
| Entity Name | Atlanticare Physician Group Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093829608 PECOS PAC ID: 8527953660 Enrollment ID: O20040218000405 |
News Archive
Predictive Biosciences today announced that the Company will be presenting results on the development of a real-time multiplexed PCR assay for detection of FGFR3 mutations in urine and tissue at the American Society of Clinical Oncology (ASCO) 2011 Genitourinary Cancers Symposium being held February 17 - 19 in Orlando, Florida. Results will also focus on the application of the assay which is currently being used in Predictive's first commercial molecular grading product, the CertNDxTM Molecular Grading Assay.
Laboratory Corporation of America® Holdings announced today that for the period of March 12, 2010 to September 11, 2010, its Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon Notes) will, subject to the terms of the Zero Coupon Notes, accrue contingent cash interest at a rate of no less than 0.125% of the average market price of a Zero Coupon Note for the five trading days ended March 9, 2010, in addition to the continued accrual of the original issue discount.
"Worldwide, evidence-based interventions are being implemented in an effort to drive down child mortality and there are some signs that they are working," a Lancet editorial states. "However, few countries are on course to meet the targets set by Millennium Development Goal 4," the editorial notes.
A third dose of the Pfizer-BioNTech vaccine significantly increased neutralizing antibody levels against SARS-CoV-2, the virus that causes COVID-19, according to new research published in the New England Journal of Medicine.
The Network for Excellence in Neuroscience Clinical Trials, or NeuroNEXT, a research program that helps streamline Phase II clinical trials for brain disorders, has been renewed for five more years, with several new centers joining the program
› Verified 3 days ago
| Entity Name | Virtua Medical Group, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649226515 PECOS PAC ID: 9830222397 Enrollment ID: O20100804000338 |
News Archive
Predictive Biosciences today announced that the Company will be presenting results on the development of a real-time multiplexed PCR assay for detection of FGFR3 mutations in urine and tissue at the American Society of Clinical Oncology (ASCO) 2011 Genitourinary Cancers Symposium being held February 17 - 19 in Orlando, Florida. Results will also focus on the application of the assay which is currently being used in Predictive's first commercial molecular grading product, the CertNDxTM Molecular Grading Assay.
Laboratory Corporation of America® Holdings announced today that for the period of March 12, 2010 to September 11, 2010, its Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon Notes) will, subject to the terms of the Zero Coupon Notes, accrue contingent cash interest at a rate of no less than 0.125% of the average market price of a Zero Coupon Note for the five trading days ended March 9, 2010, in addition to the continued accrual of the original issue discount.
"Worldwide, evidence-based interventions are being implemented in an effort to drive down child mortality and there are some signs that they are working," a Lancet editorial states. "However, few countries are on course to meet the targets set by Millennium Development Goal 4," the editorial notes.
A third dose of the Pfizer-BioNTech vaccine significantly increased neutralizing antibody levels against SARS-CoV-2, the virus that causes COVID-19, according to new research published in the New England Journal of Medicine.
The Network for Excellence in Neuroscience Clinical Trials, or NeuroNEXT, a research program that helps streamline Phase II clinical trials for brain disorders, has been renewed for five more years, with several new centers joining the program
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Adam Hill, MSN 7000 Atrium Way Ste 6, Mount Laurel, NJ 08054-3917 Ph: (856) 206-4508 | Adam Hill, MSN 520 A Lippincott Dr., Marlton, NJ 08053 Ph: (856) 596-9057 |
News Archive
Predictive Biosciences today announced that the Company will be presenting results on the development of a real-time multiplexed PCR assay for detection of FGFR3 mutations in urine and tissue at the American Society of Clinical Oncology (ASCO) 2011 Genitourinary Cancers Symposium being held February 17 - 19 in Orlando, Florida. Results will also focus on the application of the assay which is currently being used in Predictive's first commercial molecular grading product, the CertNDxTM Molecular Grading Assay.
Laboratory Corporation of America® Holdings announced today that for the period of March 12, 2010 to September 11, 2010, its Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon Notes) will, subject to the terms of the Zero Coupon Notes, accrue contingent cash interest at a rate of no less than 0.125% of the average market price of a Zero Coupon Note for the five trading days ended March 9, 2010, in addition to the continued accrual of the original issue discount.
"Worldwide, evidence-based interventions are being implemented in an effort to drive down child mortality and there are some signs that they are working," a Lancet editorial states. "However, few countries are on course to meet the targets set by Millennium Development Goal 4," the editorial notes.
A third dose of the Pfizer-BioNTech vaccine significantly increased neutralizing antibody levels against SARS-CoV-2, the virus that causes COVID-19, according to new research published in the New England Journal of Medicine.
The Network for Excellence in Neuroscience Clinical Trials, or NeuroNEXT, a research program that helps streamline Phase II clinical trials for brain disorders, has been renewed for five more years, with several new centers joining the program
› Verified 3 days ago
Jacquelyn Regina Zagone, PMHNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 777 Route 70 E Ste G101, Marlton, NJ 08053 Phone: 800-413-8020 | |
Dorothy Westlake, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1001 Rt. 73 North, Upper Level A & Main Level, Marlton, NJ 08053 Phone: 856-988-3444 | |
Phenita Sammantha Mouzon, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 777 Route 70 E Ste G101, Marlton, NJ 08053 Phone: 856-818-4020 | |
Mrs. Lisa Spurlock Abrams, APN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 765 E Route 70, Building A, Marlton, NJ 08053 Phone: 856-797-4721 | |
Rafia Nicola Grooms, DNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 765 Route 70 E Bldg A100, Marlton, NJ 08053 Phone: 856-797-4721 Fax: 856-797-4785 | |
Mrs. Yingqiao Chen, PMHNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2003 Lincoln Dr W Ste B, Marlton, NJ 08053 Phone: 856-886-8839 Fax: 856-210-1874 | |
Ms. Fleurdeliz Alabanzas Germodo, N.P. Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 141 Route 70 E Ste B, Marlton, NJ 08053 Phone: 856-596-9057 |